Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC EPS

The Earnings per Share (EPS) of Ben Tre Pharmaceutical JSC (DBT.VN) as of Nov 5, 2026 is 695.32 VND. In the previous year, Earnings per Share (EPS) was 731.78 VND — a change of -4.98% (lower).

EPS

695.32VND

YoY

-4.98%

Last updated:

Earnings per Share (EPS) of Ben Tre Pharmaceutical JSC is 2024 695.32 VND. Earnings per Share (EPS) of Ben Tre Pharmaceutical JSC was 2023 731.78 VND. It decreases by -4.98% lower compared to the previous year.

The Ben Tre Pharmaceutical JSC EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2013
1,103.30 VND
Jan 1, 2014
1,136.78 VND
Jan 1, 2015
1,978.09 VND
Jan 1, 2020
757.00 VND
Jan 1, 2021
921.43 VND
Jan 1, 2022
1,944.86 VND
Jan 1, 2023
731.78 VND
Jan 1, 2024
695.32 VND
The Ben Tre Pharmaceutical JSC EPS history
YEAREPSYoY
695.32VND-4.98%
731.78VND-62.37%
1,944.86VND+111.07%
921.43VND+21.72%
757.00VND-61.73%
1,978.09VND+74.01%
1,136.78VND+3.03%
1,103.30VND+4.30%
1,057.82VND-8.33%
1,154.00VND+1.11%
1,141.30VND+51.49%
753.40VND-27.31%
1,036.50VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

Earnings per Share (EPS) of Ben Tre Pharmaceutical JSC is 695.32 VND in 2024.

Earnings per Share (EPS) of Ben Tre Pharmaceutical JSC changed from 731.78 VND to 695.32 VND, representing a -4.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Ben Tre Pharmaceutical JSC

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Ben Tre Pharmaceutical JSC